| |
|
|
|
Aptevo Therapeutics Inc.  
|
|
0.8801 0.013 (0.01%) |
07-22 09:44 |
|
Open: |
0.8814 |
Pre close: |
0.8675 |
Target:
|
1.11
|
|
High: |
0.89 |
Low: |
0.8799 |
Resistance:
|
0.95
1.04
|
|
Volume: |
43,933 |
Market Cap: |
40M |
Support:
|
0.80
0.67
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.87
 |
MACD |
MACD(12,26):
|
0.01  |
|
MA(20): |
0.87 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
0.87 |
Stochastic Oscillator |
%K(14,3):
|
51.02 |
|
MA(250): |
2.34 |
%D(3): |
48.43 |
|
Average Volume(K) |
3-Month: |
49957
|
52-Week |
High:
|
5.80 |
|
10-Days: |
40547 |
Low: |
0.67 |
|
RSI |
RSI(14):
|
51.58 |
Change(%): |
-82.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.171 |
Return on Equity (ttm) |
-96.5 |
Shares Out. (M) |
22.41 |
|
EPS Est. Current Year |
0.590 |
Return on Assets (ttm) |
-34.3 |
Shares Float (M) |
31.53 |
|
EPS Est. Next Year |
-2.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.31 |
|
EPS Est. Next Quarter |
2.250 |
Qtrly Rev. Growth |
72.5 |
% Held by Institutions |
41.88 |
|
Forward EPS |
-1.321 |
Gross Profit (p.s.) |
-1.050 |
Shares Short (K) |
314 |
|
Book Value (p.s.) |
0.870 |
EBITDA (p.s.) |
-2.107 |
P/E |
-0.40 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.00 |
|
Profit Margin |
-199.30 |
Operating Cash Flow
(M) |
-48.29 |
P/S |
17835482.00 |
|
Operating Margin |
-190.65 |
Levered Free Cash Flow
(M) |
-26.03 |
P/CF |
-0.40 |
|
|
|
|
|
|
